Carregant...
Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
Alzheimer’s disease (AD) and treatment of the brain in aging require the development of new biologic drugs, such as recombinant proteins or gene therapies. Biologics are large molecule therapeutics that do not cross the blood-brain barrier (BBB). BBB drug delivery is the limiting factor in the futur...
Guardat en:
| Publicat a: | Front Aging Neurosci |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6966240/ https://ncbi.nlm.nih.gov/pubmed/31998120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2019.00373 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|